Medical Nutrition USA, Inc.
Medical Nutrition USA, Inc.
Medical Nutrition USA, Inc.
You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
<strong>Medical</strong> <strong>Nutrition</strong> <strong>USA</strong>, <strong>Inc</strong>.<br />
NEWS RELEASE for April 18, 2005<br />
Contact: Anne Straton (investors) Frank A. Newman<br />
Allen & Caron <strong>Inc</strong><br />
<strong>Medical</strong> <strong>Nutrition</strong> <strong>USA</strong><br />
212 691 8087 201 569 1188<br />
a.straton@allencaron.com<br />
fanewman@mnidirect.net<br />
MEDICAL NUTRITION <strong>USA</strong> SELECTS ALLEN & CARON<br />
FOR INVESTOR RELATIONS<br />
ENGLEWOOD, NJ (April 18, 2005) … <strong>Medical</strong> <strong>Nutrition</strong> <strong>USA</strong> <strong>Inc</strong> (OTCBB: MDNU), a<br />
manufacturer of nutrition-medicine products, announced that it has selected Allen & Caron <strong>Inc</strong><br />
as its investor relations agency.<br />
<strong>Medical</strong> <strong>Nutrition</strong> <strong>USA</strong> <strong>Inc</strong> (“MDNU”) develops and distributes products for nutritionally atrisk<br />
individuals under medical supervision. Its products are used primarily in long-term care<br />
facilities, hospitals, dialysis clinics and bariatric surgery clinics for patients with specific medical<br />
conditions such as bed sores and malnutrition; for patients undergoing renal dialysis and<br />
chemotherapy; and patients who have had bariatric surgery. The Company’s lead products<br />
include Pro-Stat and the pbs <strong>Nutrition</strong>al Support System.<br />
<strong>Medical</strong> <strong>Nutrition</strong> Chairman and CEO Frank A. Newman commented, “We are at a flexion<br />
point where demand for our products is increasing rapidly, and we have moved from a cash-burn<br />
to a cash-positive state. We believe it is time to launch a proactive and professionally executed<br />
investor relations program to increase the number of people in the investment community who<br />
know about us. Following a review of such firms, we selected Allen & Caron because they<br />
demonstrated an appropriate level of understanding of our prospects, and have a good record<br />
working with smaller, growing healthcare companies.”<br />
Allen & Caron Chairman and CEO Joe Allen said, “<strong>Medical</strong> <strong>Nutrition</strong> products are effective<br />
against some of the most pernicious and widespread conditions afflicting patients in nursing<br />
environments. Most people – investors or not – have had some experience, even at second-hand,<br />
with long-term care. The high incidence of bed sores is a national disgrace, and should make<br />
Pro-Stat a product in great demand. This year will be an important one for <strong>Medical</strong> <strong>Nutrition</strong>,<br />
with a crossover to profitability and an increase in market share. We believe the investment<br />
community will respond with interest and enthusiasm.”<br />
About Allen & Caron<br />
Allen & Caron is a full service corporate, investor and marketing communications agency<br />
serving the needs of public companies. The Allen & Caron international client base includes<br />
emerging growth companies in a range of industry segments. It maintains offices in Irvine,<br />
California, New York City and London, England.<br />
About <strong>Medical</strong> <strong>Nutrition</strong> <strong>USA</strong><br />
<strong>Medical</strong> <strong>Nutrition</strong> <strong>USA</strong>, <strong>Inc</strong>. (MDNU) is a developer of nutritional products designed for<br />
specific medical conditions including bed sores, for patients undergoing dialysis or<br />
chemotherapy, and for post-bariatric surgery nutritional needs sold to long-term care facilities,<br />
MORE-MORE-MORE
MEDICAL NUTRITION <strong>USA</strong> SELECTS ALLEN & CARON<br />
Page 2-2-2<br />
hospitals, dialysis clinics and bariatric surgery clinics. The Company’s lead products include<br />
Pro-Stat and <strong>Nutrition</strong>al Support System. Pro-Stat has proven effective for nursing home,<br />
dialysis and bariatric surgery patients due to its high protein-to-volume ratio, small serving size,<br />
ease of administration and low amounts of sodium, potassium and phosphorous. For more<br />
information on <strong>Medical</strong> <strong>Nutrition</strong> products, please visit www.pro-stat.com, or call us at<br />
1 800 221 0308.<br />
Safe Harbor Statement<br />
This press release contains forward-looking statements that are subject to certain risks and uncertainties.<br />
Although we believe that the expectations reflected in any of our forward-looking statements are reasonable, actual<br />
results could differ materially from those projected or assumed. Risks and uncertainties that could cause or<br />
contribute to such material difference include, but are not limited to, general economic conditions, changes in<br />
customer demand, changes in trends in the nursing home, renal care, health food and bariatric surgery markets,<br />
changes in competitive pricing for products, and the impact of our competitors new product introductions. Our<br />
future financial condition and results of operations, as well as any forward-looking statements are subject to change<br />
and inherent risk and uncertainties. Other important factors that may cause actual results to differ materially from<br />
those expressed in forward-looking statement are discussed in the Company’s Securities and Exchange Commission<br />
filings , including the report on Form 10-K for the fiscal year ended January 31, 2005, which the Company filed on<br />
April 1, 2005.<br />
# # # #
Change language